Cintia Piccina

Insider Reports History

Location
Oxfordshire, United Kingdom
Signature
/s/ Cintia Piccina
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cintia Piccina:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allovir, Inc. Chief Commercial Officer Common Stock 147,000 $98,608 $0.6708 03 Jul 2023 Direct
Adaptimmune Therapeutics PLC Chief Commercial Officer American Depositary Shares representing Ordinary Shares 18,421 $10,588 $0.5748 15 Jan 2025 Direct
Adaptimmune Therapeutics PLC Chief Commercial Officer Option to purchase Ordinary Shares 1,074,696 20 Feb 2025 Direct
Allovir, Inc. Chief Commercial Officer Stock Option (Right to Buy) 273,000 03 Jul 2023 Direct

Insider Reports Filed by Cintia Piccina

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADAP Adaptimmune Therapeutics PLC 20 Feb 2025 2 $0 4 Chief Commercial Officer 20 Feb 2025, 17:32
ADAP Adaptimmune Therapeutics PLC 15 Jan 2025 1 -$7,467 4 Chief Commercial Officer 15 Jan 2025, 16:18
ADAP Adaptimmune Therapeutics PLC 18 Jun 2024 1 -$22,814 4 Chief Commercial Officer 18 Jun 2024, 17:00
ADAP Adaptimmune Therapeutics PLC 18 Mar 2024 2 $0 4 Chief Commercial Officer 18 Mar 2024, 17:00
KLRS Allovir, Inc. 03 Jul 2023 2 $0 4 Chief Commercial Officer 05 Jul 2023, 17:00
KLRS Allovir, Inc. 12 Jun 2023 0 $0 3 Chief Commercial Officer 21 Jun 2023, 17:00
ADAP Adaptimmune Therapeutics PLC 31 Jan 2023 1 -$22,230 4 Chief Commercial Officer 31 Jan 2023, 20:02
ADAP Adaptimmune Therapeutics PLC 17 Jan 2023 3 $0 4 Chief Commercial Officer 17 Jan 2023, 20:02
ADAP Adaptimmune Therapeutics PLC 01 Aug 2022 1 -$37,314 4 Chief Commercial Officer 01 Aug 2022, 21:00
ADAP Adaptimmune Therapeutics PLC 31 Jan 2022 3 $0 4 Chief Commercial Officer 31 Jan 2022, 20:05
ADAP Adaptimmune Therapeutics PLC 31 Jan 2022 0 $0 3 Chief Commercial Officer 31 Jan 2022, 20:00